Search Results - "Böker, K. H."

Refine Results
  1. 1

    Distinct roles of free leptin, bound leptin and soluble leptin receptor during the metabolic‐inflammatory response in patients with liver cirrhosis by OCKENGA, J., TIETGE, U. J. F., BÖKER, K. H. W., MANNS, M. P., BRABANT, G., BAHR, M. J.

    Published in Alimentary pharmacology & therapeutics (01-06-2007)
    “…Summary Background Alteration of the leptin system appears to play a role in the inflammatory–metabolic response in catabolic diseases such as chronic liver…”
    Get full text
    Journal Article
  2. 2

    Real‐world use, effectiveness and safety of anti‐viral treatment in chronic hepatitis C genotype 3 infection by Cornberg, M., Petersen, J., Schober, A., Mauss, S., Böker, K. H. W., Link, R., Günther, R., Serfert, Y., Pfeiffer‐Vornkahl, H., Manns, M. P., Sarrazin, C., Hüppe, D., Berg, T., Niederau, C.

    Published in Alimentary pharmacology & therapeutics (01-03-2017)
    “…Summary Background Treatment of chronic hepatitis C genotype 3 (GT3) is more challenging compared with other genotypes. Since 2014, several new treatment…”
    Get full text
    Journal Article
  3. 3

    Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation by Arkenau, H T, Stichtenoth, D O, Frölich, J C, Manns, M P, Böker, K H W

    Published in Zeitschrift für Gastroenterologie (01-11-2002)
    “…Chronic liver diseases are accompanied by changes in splanchnic and systemic circulation. These changes are characterised by a reduction in peripheral vascular…”
    Get more information
    Journal Article
  4. 4

    Comparison of matrix metalloproteinase expression in normal and cirrhotic human liver by LICHTINGHAGEN, R, BREITENSTEIN, K, ARNDT, B, KÜHBACHER, T, BÖKER, K. H. W

    “…To study the extend of ongoing tissue remodelling in end-stage cirrhosis, the expression of different matrix metalloproteinases [interstitial collagenase…”
    Get full text
    Journal Article
  5. 5

    Hypermetabolism in clinically stable patients with liver cirrhosis by Muller, M.J, Bottcher, J, Selberg, O, Weselmann, S, Boker, K.H.W, Schwarze, M, Muhlen, A. von zur, Manns, M.P

    Published in The American journal of clinical nutrition (01-06-1999)
    “…Background: Hypermetabolism has a negative effect on prognosis in patients with liver cirrhosis. Its exact prevalence and associations with clinical data, the…”
    Get full text
    Journal Article Conference Proceeding
  6. 6
  7. 7

    Differential distribution of five members of the matrix metalloproteinase family and one inhibitor (TIMP-1) in human liver and skin by Geisler, S, Lichtinghagen, R, Böker, K H, Veh, R W

    Published in Cell and tissue research (01-07-1997)
    “…Matrix metalloproteinases represent a family of zinc-dependent proteolytic enzymes thought to be involved in normal and disease-related tissue remodeling…”
    Get full text
    Journal Article
  8. 8

    Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil by BARKMANN, A, NASHAN, B, SCHLITT, H. J, SCHMIDT, H. H. J, BÖKER, K. H. W, EMMANOUILIDIS, N, ROSENAU, J, BAHR, M. J, HOFFMANN, M. W, MANNS, M. P, KLEMPNAUER, J

    Published in Transplantation (15-05-2000)
    “…Renal dysfunction caused by treatment with the calcineurin inhibitors (CNI) is a major problem in the long-term course after liver transplantation. In 22 liver…”
    Get full text
    Journal Article
  9. 9

    Improved outcome of chronic hepatitis B after heart transplantation by long-term antiviral therapy by Potthoff, A., Tillmann, H. L., Bara, C., Deterding, K., Pethig, K., Meyer, S., Haverich, A., Böker, K. H. W., Manns, M. P., Wedemeyer, H.

    Published in Journal of viral hepatitis (01-11-2006)
    “…Chronic hepatitis B progresses to cirrhosis in the majority of immunosuppressed patients. The outcome of long‐term antiviral therapy in HBV‐infected organ…”
    Get full text
    Journal Article
  10. 10

    Long‐term outcome of hepatitis C virus infection after liver transplantation by Böker, K. H., Dalley, G., Bahr, M. J., Maschek, H., Tillmann, H. L., Trautwein, C., Oldhaver, K., Bode, U., Pichlmayr, R., Manns, M. P.

    Published in Hepatology (Baltimore, Md.) (01-01-1997)
    “…We analyzed the long‐term clinical course of 71 patients with RNA‐positive hepatitis C virus (HCV) infection after liver transplantation. Patients with…”
    Get full text
    Journal Article
  11. 11

    Hepatitis B virus mutations in the pre-S genome before and after liver transplantation by TRAUTWEIN, C, SCHREM, H, TILLMANN, H. L, KUBICKA, S, WALKER, D, BÖKER, K. H. W, MASCHEK, H.-J, PICHLMAYR, R, MANNS, M. P

    Published in Hepatology (Baltimore, Md.) (01-09-1996)
    “…Mutational changes in the pre-S region of hepatitis B virus (HBV) were analyzed in 20 patients who experienced HBV reinfection after orthotopic liver…”
    Get full text
    Journal Article
  12. 12

    Prostaglandin E plus famciclovir--a new concept for the treatment of severe hepatitis B after liver transplantation by Böker, K H, Ringe, B, Krüger, M, Pichlmayr, R, Manns, M P

    Published in Transplantation (27-06-1994)
    “…New concepts for the treatment of hepatitis B in immunocompromised patients are urgently needed. We describe our first experience with the new antiviral agent…”
    Get more information
    Journal Article
  13. 13

    Tissue inhibitors of metalloproteinases in liver and serum/plasma in chronic active hepatitis C and HCV-induced cirrhosis by Böker, K H, Pehle, B, Steinmetz, C, Breitenstein, K, Bahr, M, Lichtinghagen, R

    Published in Hepato-gastroenterology (01-05-2000)
    “…The development of liver cirrhosis can be described as a process of tissue remodeling, which involves increased matrix turnover. In order to determine whether…”
    Get more information
    Journal Article
  14. 14

    Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b by Krüger, Martin, Böker, Klaus H.W., Zeidler, Henning, Manns, Michael P.

    Published in Journal of hepatology (01-04-1997)
    “…Background: The association between polyarteritis nodosa and viral hepatitis B infection is well established and still remains a therapeutic challenge…”
    Get full text
    Journal Article
  15. 15

    Famciclovir treatment of chronic hepatitis B in heart transplant recipients : A prospective trial by WEDEMEYER, H, BÖKER, K. H. W, HAVERICH, A, MANNS, M. P, PETHIG, K, PETZOLD, D. R, FLEMMING, P, TILLMANN, H. L, VOLLMAR, J, BASTÜRK, M, GOLDMANN, E, GRIFFIN, K. E

    Published in Transplantation (27-11-1999)
    “…Hepatitis B may take a rapid and aggressive course in patients under immunosuppression. Nucleoside analogues have been shown to suppress viral replication…”
    Get full text
    Conference Proceeding Journal Article
  16. 16

    Hepatoma with severe non-islet cell tumor hypoglycemia by Tietge, Uwe J F, Schöfl, Christof, Ocran, Kenneth W, Wagner, Siegfried, Böker, Klaus H.W., Brabant, Georg, Zapf, Jürgen, Manns, Michael P

    Published in The American journal of gastroenterology (01-06-1998)
    “…We report a 22-yr-old male patient with chronic hepatitis B and a large, well differentiated hepatoma who developed episodes of symptomatic fasting…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Serum laminin P1 levels do not reflect critically elevated portal pressure in patients with liver cirrhosis by Bahr, M J, Böker, K H, Horn, W, Günzler, V, Manns, M P

    Published in Hepato-gastroenterology (01-07-1997)
    “…Laminin P1 serum levels run parallel to the accumulation of hepatic extracellular matrix in patients with liver cirrhosis. Recent studies reported a…”
    Get more information
    Journal Article
  20. 20

    Tacrolimus (FK 506) biotransformation in primary rat hepatocytes depends on extracellular matrix geometry by Bader, A, Knop, E, Böker, K H, Crome, O, Frühauf, N, Gonschior, A K, Christians, U, Esselmann, H, Pichlmayr, R, Sewing, K F

    “…Established in vitro models for studies of hepatic drug biotransformation include the use of primary hepatocytes. In normal liver the space of Disse provides…”
    Get full text
    Journal Article